MPO and cardiovascular disorder: Additionally, oxidatively modified HMGB1, along with ROS and myeloperoxidase (MPO) released by neutrophils, can promote the formation and rupture of atherosclerotic plaques, thereby accelerating the progression of cardiovascular disease [243].